Western Blotting Market Size, Share, and Trends 2024 to 2033

Western Blotting Market Size and Growth

The global western blotting market size was USD 989.47 million in 2023, calculated at USD 1,053.98 million in 2024 and is expected to reach around USD 1,860.86 million by 2033, expanding at a CAGR of 6.52% from 2024 to 2033. Western blotting offers more benefits than another antibody-based detection assay; it requires fewer reagents, many analyses can be done with the same protein transfer, and it provides accurate qualitative and quantitative data about the protein of interest. These factors help to the growth of the market.

Anesthesia Drugs Market Key Takeaways

• The North America western blotting market size reached USD 356.21 million in 2023 and is expected to attain around USD 679.21 million by 2033, poised to grow at a CAGR of 6.66% between 2024 and 2033.
• North America dominated the western blotting market with the highest revenue share of 36% in 2023.
• Asia Pacific is estimated to be the fastest-growing during the forecast period of 2024-2033.
• By products, the electrophoresis blotting systems segment dominated the market in 2023, and the segment is expected to grow the fastest during the forecast period.
• By application, the medical diagnostics segment has contributed more than 51% of revenue share in 2023.
• By application, the scientific research segment is expected to grow significantly during the forecast period.
• By end-use, the diagnostic laboratories segment dominated the western blotting market in 2023 and is expected to grow fastest during the forecast period.

U.S. Western Blotting Market Size and Growth 2024 to 2033

The U.S. western blotting market size was exhibited at USD 249.35 million in 2023 and is projected to be worth around USD 478.85 million by 2033, poised to grow at a CAGR of 6.74% from 2024 to 2033.

North America dominated the western blotting market in 2023. Increased focus on personalized medicine, increased research funding, and rising investment in proteomics research help the growth of the market in the North American region. Increased demand for synthetic biology solutions, supportive government initiatives, and decreasing sequencing costs help the growth of the biotechnology industries in the United States.

Asia Pacific is estimated to be the fastest-growing during the forecast period of 2024-2033. China is the leading country for the growth of the western blotting market in the Asia Pacific region. Increasing demand for medical diagnostics and growing pharmaceutical industries in China contribute to the growth of the market.

• In March 2024, a GreatPrep EasyECL chemiluminescent substrate was launched by Chennai-based VFL Sciences. This is the first kit/reagent from VFL Sciences for western blotting use. This kit or reagent offers detection levels from mid-picogram to low femtograms and also offers error-free results.

Market Overview

Western blotting technique or protein immunoblot is used for the detection and quantification of specific protein molecules in the given complex protein sample. The Western blotting market deals with industries for applications including food & beverages, agriculture, medical diagnostics, scientific research, and other applications. Western blotting is the most commonly used analytical method in fundamental cell and molecular biology research, disease, and drug development to examine molecular function. The benefits of western blotting include its use in protein separation by electrophoresis, followed by western blotting, which can offer more precision than other antibody-based detection assays. ELISA. The western blotting process requires the use of a small number of reagents, and the same protein transfer may be used for the various analyses. These factors help to the growth of the market.

Anesthesia Drugs Market Growth Factors

• Western blotting is an important cell and molecular biology research technique that separates and identifies proteins, which helps the growth of the market.
• Protein separation by electrophoresis followed by western blotting offers more precision than other antibody-based detection assays that help the growth of the market.
• The western blotting process only requires the use of a small amount of reagents, and the same protein transfer may be used for many analyses. These factors help to the growth of the western blotting market.
• Quantitative western blotting is important for accurate characterization of the biochemical attributes of protein. Western blotting may produce qualitative and quantitative data about the protein of interest.

Western Blotting Market Scope

Anesthesia Drugs Market Dynamics

Driver

Rising prevalence of HIV worldwide

For the detection of HIV, the western blotting method is highly used. The western blot test separates the blood and detects the specific proteins called HIV antibodies that indicate HIV infection. For a positive HIV diagnosis, a western blot test is used. The rising prevalence of HIV worldwide helps to the growth of the western blotting market. Early diagnosis and testing are important for effective prevention and management of HIV. Western blotting is also used to ensure a positive ELISA. Western blotting test is a simple blood test. It does not require preparation or fasting in any way. These factors help to the growth of the market.

Restraint

Need for alternative technologies

There is a need for alternative technology due to the disadvantages of western blotting, including incidental oxidation or phosphorylation of proteins that may result in multiple bands becoming visible after sampling the process. Subject to false or subjective results. Western blotting is a challenging technique that requires well-trained staff. It requires primary antibodies for the protein of interest, and it may exhibit off-target binding, which leads to poorer results. These factors can hamper the growth of the western blotting market.

Opportunity

Advanced technologies

In clinical and research settings, the western blotting technique is used to identify proteins and characterize their levels. There is an opportunity for western blotting improvement by creating more sensitive, advanced, and automatic techniques. New methods like microchip electrophoresis, automated microfluid western blotting, DigiWest, capillary electrophoresis, and single-cell resolution western blot have all been developed to reduce problems that are linked with western blotting techniques. For western blotting, innovative instrument developments and increased sensitivity offer new possibilities for increasing the clinical performance of the western blot. These factors help to the growth of the western blotting market.

Product Insights

The electrophoresis blotting systems segment dominated the market in 2023, and the segment is expected to grow the fastest during the forecast period. Electrophoresis blotting, also known as electroblotting, is a technique used in immunogenetics, molecular biology, and biochemistry to transfer nucleic acid or proteins onto a membrane by using nitrocellulose or PVDF after gel electrophoresis. This technique is used for nucleic acid separation or immobilization of proteins on a solid membrane. The electrophoresis blotting system benefits include improved diagnosis, throughput, fast & easy technique, mass sensitivity, automation, and consistent and dependable results. These factors help the growth of the electrophoresis blotting system segment and contribute to the growth of the western blotting market.

Application Insights

The medical diagnostics segment dominated the market in 2023 and is expected to grow fastest during the forecast period. Western blotting is a widely used analytical technique in immunogenetics and molecular biology. In medical diagnostics, western blotting is used for the diagnosis of infectious diseases like HIV, prion disease, hepatitis B diseases, and autoimmune diseases like paraneoplastic disease. Western blotting can provide confirmed results for medical diagnostics because their results are quicker and less ambiguous than other methods. These factors help to the growth of the medical diagnostics segment and contribute to the growth of the western blotting market.

The scientific research segment is expected to grow significantly during the forecast period. Western blotting is a leading and widely used technique in scientific and biomedical research. Researchers can detect specific proteins from a complex mixture of proteins extracted from cells by using western blotting, which helps detect diseases. Western blotting is a simple, rapid, unique, and widely used tool with definite results and easy interpretation. The benefits of western blotting in scientific research include high specificity, semi-quantitative analysis, flexibility, ease of use, and detection sensitivity, which can help the growth of the scientific research segment and contribute to the growth of the western blotting market.

End-use Insights

The diagnostic laboratories segment dominated the western blotting market in 2023 and is expected to grow fastest during the forecast period. The western blotting is highly used in diagnostic laboratories. The benefits of western blotting include protein detection, quantitative analysis, safety, and sensitivity. The clinical applications of western blotting include diagnosis of infectious diseases like Lyme disease, HIV, and hepatitis C, and autoimmune disorders like myositis and paraneoplastic disease. These factors help to the growth of the diagnostic laboratories segment and contribute to the growth of the market.

Anesthesia Drugs Market Companies

• Leinco Technologies
• Takara Bio Inc.
• ICL, Inc.
• Cell Signaling Technology, Inc.
• GenScript
• ElabScience Biotechnology Inc.
• HiMedia Laboratories
• Azure Biosystem Inc.
• Advansta Inc
• SBH Sciences
• Bio-Techne
• LI-COR, Inc.
• Bio-Rad Laboratories
• Merck KGaA
• Lumigen, Inc.
• Hoffmann-La Roche Ltd
• GE Healthcare
• Thermo Fischer Scientific Inc.

Recent Developments

• In January 2022, Bio-Techne launched their stellar NIR spectroscopy/IR (near-infrared spectroscopy/infrared) detection modules for an automated multichannel traditional western blotting system, Jess, under the ProteinSimple brand.
• In February 2024, a new product line offering anti-HCP antibodies with greater than 95% coverage was launched by a leading proteomics service provider, Applied Biomics, Inc. The company provides Anti-E. Coli, Anti-CHO, and Anti-HEK293 HCP antibodies. These antibodies can be used for immune-precipitation, ELISA, 1D, or 2D western blotting.

Segments Covered in the Report

By Products

• Electrophoresis Blotting Systems
  • Automated Dry Blotting Systems
  • Semi-dry Blotting Systems
  • Traditional Wet Transfer Blotting Systems 
• Reagents & Kits
  • Chromogenic Reagents Kits
  • Chemiluminescent Reagents Kits
    • Horseradish Peroxidase (HRP) Substrate
    • Alkaline Phosphate (AP) Substrate
  • Fluorescent Reagents
  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Buffer Kits
• Transfer Membranes

By Application

• Scientific Research
• Medical Diagnostics
• Agricultural Application
• Food & Beverages
• Other Applications

By End-use

• Diagnostics Laboratories
• Research Institutions
• Pharmaceutical & Biotechnology Companies

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa